InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Browse the complete record of transactions filed by Prior Stephen David. Officer active across 1 company, notably AN2 Therapeutics, Inc.. In total, 5 disclosures have been logged. Split: 0 buy · 3 sells. Total volume traded: €6k. Activity tracked since 4 November 2024. The latest transaction was filed on 5 January 2026 (Cession). Regulator: SEC (Form 4). The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 of 5 declarations
Stephen David Prior has filed 4 forms in total. In the 4 most recent filings we hold, covering the period from 2024-11-05 to 2025-11-06, there were 0 in purchases and 3407 in sales, with transactions mainly described as sales. The filings concern AN2 Therapeutics, Inc., where he is Chief Strategy Officer.